FDA Approved: UVADEX — Supplemental Application (Therakos LLC)

View source ↗

Summary

FDA approved a supplemental application for UVADEX (methoxsalen) from Therakos LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Graft-versus-host Disease
• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• UVADEX (methoxsalen)

Snippet

SUPPL AP for UVADEX (METHOXSALEN)